Quotes Madrigal Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
20:55:02 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 445.70 EUR | +0.32% |
|
-0.93% | -10.00% |
| 09-24 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 09-23 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
Stock exchange
Deutsche Boerse AG
YDO1 445.70 €
+0.32%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| MDGL | 499.71USD | -0.84% | 102M $ | ||
CBOE
| MDGL | 500.11USD | -0.69% | 3.96M $ | |
|
Tradegate
| YDO1 | 445.00EUR | +0.09% | 445 € | |
|
Deutsche Boerse AG
| YDO1 | 445.70EUR | +0.32% | 0 € | |
|
Börse Stuttgart
| YDO1 | 444.10EUR | -0.02% | 0 € | |
|
Boerse Muenchen
| YDO1 | 447.80EUR | +0.31% | 0 € | |
|
Borsa Italiana
| 1MDGL | 448.90EUR | +0.09% | 0 € | |
|
Xetra
| YDO1 | 445.90EUR | -0.69% | 0 € |
Quotes 5-day view: Madrigal Pharmaceuticals, Inc.
Delayed Quote Deutsche Boerse AG
| 25/09/2026 | 28/09/2026 | 29/09/2026 | 30/09/2026 | 01/10/2026 | |
|---|---|---|---|---|---|
| Last | €450.50 | €452.90 | €445.30 | €444.30 | €445.00 |
| Volume | 3 | 0 | 5 | 0 | 0 |
| Change | +0.13% | +0.53% | -1.68% | -0.22% | +0.16% |
| Opening | €447.30 | €448.00 | €450.20 | €446.00 | €442.10 |
| High | €456.40 | €455.10 | €451.60 | €451.50 | €446.40 |
| Low | €447.00 | €445.80 | €445.30 | €444.30 | €442.10 |
Performance
| 1 day | +0.32% | ||
| 1 week | -0.93% | ||
| Current month | +0.32% | ||
| 1 month | -3.47% | ||
| 3 months | -1.39% | ||
| 6 months | -1.91% | ||
| Current year | -10.00% | ||
| 1 year | +16.22% | ||
| 3 years | +225.21% | ||
| 5 years | +555.44% | ||
| 10 years | +3,914.59% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
2
Daily volume ratio
0
Avg. Volume 20 sessions
891.4
Avg. Volume 20 sessions USD
1,001.41
Record volume 1
2,000
Record volume 2
1,025
Record volume 3
853
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
11,643,555,338
Market Cap (USD)
11,643,555,338
Net sales (USD)
958,403,000
Number of employees
915
Sales / Employee (USD)
1,047,435
Free-Float
94.17%
Free-Float capitalization (EUR)
12,345,317,247
Free-Float capitalization (USD)
10,965,110,779
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
447.74
Moving average 20 days
456.92
Moving average 50 days
454.12
Moving average 100 days
450.05
Price spread / (MMA5)
+0.46%
Price spread / (MMA20)
+2.52%
Price spread / (MMA50)
+1.89%
Price spread / (MMA100)
+0.98%
RSI 9 days
37.57
RSI 14 days
42.79
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.32% | -0.93% | +16.22% | +225.21% | 11.64B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.81% | +27.25% | +82.72% | 60.14B | |
| -2.54% | -1.65% | +4.86% | +31.72% | 48.15B | |
| -3.02% | -5.20% | +27.94% | +32.51% | 44.25B | |
| +0.31% | +3.02% | +348.95% | +643.82% | 43.99B | |
| -1.96% | -0.33% | +7.04% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +10.10% | +51.23% | 29.97B | |
| -3.39% | +2.26% | +28.80% | +21.93% | 29.31B | |
| -4.86% | -10.66% | -26.27% | +330.06% | 24.93B | |
| Average | -0.82% | -0.08% | +49.43% | +161.28% | 40.84B | |
| Weighted average by Cap. | -0.41% | +0.11% | +56.58% | +147.98% |
Historical Quotes: Madrigal Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 442.1 |  | 455.1 |
| 1 month | 442.1 | | 469.7 |
| Current year | 354 | | 506.4 |
| 1 year | 347.5 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 11.31 | | 523.2 |
Monthly variations
Annual variations
| 2026 | -10.14% | ||
| 2025 | +66.79% | ||
| 2024 | +42.47% | ||
| 2023 | -24.49% | ||
| 2022 | +280.69% | ||
| 2021 | -17.67% | ||
| 2020 | +6.84% | ||
| 2019 | -8.11% | ||
| 2018 | +15.57% | ||
| 2017 | +441.13% | ||
| 2016 | +5,395.02% |
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
- Quotes Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
